Carsten Thiel On The Infection Rate Of COVID-19
As the fight against coronavirus wages on, expert Carsten Thiel estimates that up to 60% of all socially active people are likely to get infected with COVID-19. While confusion continues to surround the spread of the virus and the best approach to fight it, statistics continue to reveal the climbing infection rate of the novel coronavirus. With 60% of socially active individuals likely to get the virus, many government officials are unsure of how best to proceed with reopening businesses and schools. View Related Info Here.
The U.S. Fights COVID-19
According to President Trump, the United States is creating a vaccine for the virus. While the vaccine is yet to be made, experts like Thiel highlight the importance of preventative actions. By reducing one’s level of social interaction, taking precautions with sanitizing and washing one’s hands, our actions can have significant implants on the spread of the virus.
As the virus is highly contagious and easy to spread, typical measures for fighting diseases and viruses aren’t effective on COVID-19. While the world works quickly to create a vaccine, Carsten Thiel reveals that the coronavirus crisis is bringing America’s current healthcare system to its knees.
While socially distant measures are still in practice, Thiel points out that others can effectively reduce their exposure to the virus by taking a proactive approach. Though a vaccine is in the works, Thiel reminds Americans it’s best to continue to practice preventative measures and exercise caution when around others.
Carsten Thiel is a veritable expert in the fields of pharmaceuticals and the biochemistry industry. After finishing his bachelor’s degree in biochemistry, Thiel went on to earn a Ph.D. in molecular biology.
In recent years he has worked for the likes of Hoffmann La Roche, Amgen, Avion Pharmaceuticals, and similar companies. Amidst the coronavirus pandemic, Thiel frequently weighs in on how countries can prepare themselves for a socially distant future.
See also: https://www.niceguysonbusiness.com/950-carsten-thiel-innovation-entrepreneurship-biotech-industry/